SOFIE

About:

SOFIE is a molecular imaging company focused on empowering people with new PET technologies.

Website: https://sofie.com/

Twitter/X: sofiebio

Top Investors: National Institutes of Health, Jubilant Biosys, Cycad Group, Trilantic North America, Tata Industries Limited

Description:

SOFIE brings that vision to life by increasing the adoption and application diversity of theranostics by removing the cost and complexity traditionally associated with the technology. With a full line of imaging and radiochemistry systems and a premier radiopharmacy network and contract manufacturing organization to supply novel agents for diagnosis and therapy, the company is dedicated to improving patient health.

Total Funding Amount:

$44.6M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Culver City, California, United States

Founded Date:

2008-01-01

Contact Email:

inquiry(AT)sofiebio.com

Founders:

Johannes Czernin, Michael Phelps, Owen Witte

Number of Employees:

251-500

Last Funding Date:

2024-01-28

IPO Status:

Private

Industries:

© 2025 bioDAO.ai